doi: 10.1038/s41467-020-20790-0 11 KadlecAOBeyerAMAit-AissaKGuttermanDD
The evidence for GLP-1 medications in treating NASH (the more severe form of fatty liver disease) is particularly impressive: Liraglutide achieved histological resolution of steatohepatitis in 39% of cases after 48 weeks, compared to just 9% in placebo groups 20 Patients taking liraglutide had 4.5 times higher likelihood of NASH resolution than those on placebo 20 Semaglutide demonstrated NASH resolution in 59% of participants versus 17% in placebo groups 21 We offer FibroScan technology to measure liver stiffness and fat content, helping us monitor your progress while on GLP-1 therapy
However, once you already have lymphedema, the situation becomes more nuanced
Finally, there's the matter of accurate dosing
Eden operates in all 50 states, uses PCAB-accredited 503A compounding pharmacies with third-party batch testing, and includes 24/7 provider messaging, nutritional guidance, meal plans, and a private community
Why its popular: Visibility is the main drawyou can watch the entire process, which helps build confidence during those first few injections